Abstract
Currently more and more high-throughput biotechnologies have been armed by immunologists to explore the pathological mechanism of different autoimmune diseases. The new wave of approaches for the integrated understanding of human immune system based on high-throughput methods, corresponding mathematical and computational tools are increasing. This paper described the combination tendency of multiple methods to investigate the whole immune process at different levels including transcription, translation and post-translation modification, using microarray, Luminex and CyTOF as an example. When proper high-throughput technologies were used in combination, there will be more comprehensive recognition on immune system. The application of such techniques will promote deeper and more integrated study in the immunization field, and become a promising study strategy in this field.
Keywords: Autoimmune disease (AID), CyTOF, high-throughput, luminex, microarray, multiplex high-throughput biotechnologies.
Current Pharmaceutical Analysis
Title:Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases
Volume: 11 Issue: 3
Author(s): Yiping Xun, Guangyu Chen and Hongwu Du
Affiliation:
Keywords: Autoimmune disease (AID), CyTOF, high-throughput, luminex, microarray, multiplex high-throughput biotechnologies.
Abstract: Currently more and more high-throughput biotechnologies have been armed by immunologists to explore the pathological mechanism of different autoimmune diseases. The new wave of approaches for the integrated understanding of human immune system based on high-throughput methods, corresponding mathematical and computational tools are increasing. This paper described the combination tendency of multiple methods to investigate the whole immune process at different levels including transcription, translation and post-translation modification, using microarray, Luminex and CyTOF as an example. When proper high-throughput technologies were used in combination, there will be more comprehensive recognition on immune system. The application of such techniques will promote deeper and more integrated study in the immunization field, and become a promising study strategy in this field.
Export Options
About this article
Cite this article as:
Xun Yiping, Chen Guangyu and Du Hongwu, Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases, Current Pharmaceutical Analysis 2015; 11 (3) . https://dx.doi.org/10.2174/1573412911666150121233916
DOI https://dx.doi.org/10.2174/1573412911666150121233916 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases
Reviews on Recent Clinical Trials Blood Brain Barrier Compromise with Endothelial Inflammation may Lead to Autoimmune Loss of Myelin during Multiple Sclerosis
Current Neurovascular Research Effect of Recombinant Human Thymosin-α1, an Immuno-Modulating Peptide with 28 Amino Acids, on the Activity of Cytochrome P450s
Drug Metabolism Letters The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells
Current Immunology Reviews (Discontinued) Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA
Protein & Peptide Letters Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry CCR2 Antagonists
Current Topics in Medicinal Chemistry Discovery of Small Molecule Inhibitors for Prevention of Complement- Mediated Immune Hemolysis
Drug Design Reviews - Online (Discontinued) Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Current Pharmaceutical Design α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Current Medicinal Chemistry Editorial (Thematic Issue: Biologics in Autoimmune Diseases)
Current Pharmaceutical Biotechnology The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Cytokines and their Antagonists as Therapeutic Agents
Current Medicinal Chemistry Functional Genome and Proteome Analyses of Cutaneous Autoimmune Diseases
Current Pharmaceutical Design Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism